A 2-Compartment Bone Tumor Model for Testing the Efficacy of Cancer Drugs
A. Komez, A. Buyuksungur, E. Antmen, W. Swieszkowskic, N. Hasirci, V. Hasirci
This paper develops a 3D bone tumor model to study cell interactions, migration, and drug efficacy, finding Doxorubicin reduces Saos-2 cell viability by 7-fold in the model.
bioRxiv · Nov 4, 2019 · PreprintBioengineering